Double-blind controlled study of pergolide mesylate in the treatment of Parkinson's disease.
Olanow
C W
CW
Department of Neurology, University of South Florida, Tampa 33612.
Alberts
M J
MJ
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D010479:Pergolide / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D011897:Random Allocation
D010479:Pergolide